Please Wait.....
Report
Veterinary Pain Management Market Assessment, By Product [Drugs, Devices], By Application [Joint Pain, Post-Operative Pain, Cancer, Others], By Animal Type [Companion Animals, Livestock], By End-user [Companion Veterinary Hospitals, Veterinary Clinics, Drug Stores and Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
Market Report I 2024-07-31 I 231 Pages I Market Xcel - Markets and Data
Global veterinary pain management market is projected to witness a CAGR of 6.36% during the forecast period 2024-2031, growing from USD 1.85 billion in 2023 to USD 3.04 billion in 2031. The market has seen considerable growth and is poised for further manifold expansion in the future, indicating its potential as a profitable investment opportunity. The processes and therapies used to relieve pain in animals while ensuring their comfort and quality of life is referred to as veterinary pain management. It encompasses a broad range of uses, including the management of pain brought on by surgeries, chronic illnesses, injuries, and other medical conditions through the use of analgesics, anti-inflammatory drugs, physical therapy, and alternative therapies like acupuncture and laser therapy. In order to keep their animals comfortable and pain-free, pet owners are becoming more conscious of animal welfare, which has raised demand for pain management products and services. Still, a lot of pet owners do not yet realize the importantance of managing their pets' suffering. This ignorance may result in underdiagnosis and undertreatment, which could be detrimental to their pet's health. Pet owners may find it difficult to afford veterinary pain management goods and services, especially in underdeveloped regions, due to their comparatively high cost. Certain painkillers may have adverse consequences that are dangerous to animals. The veterinary industry is experiencing a scarcity of pain management professionals, which may restrict access to specialized pain management services. Strict regulatory standards must be met for pain management medications intended for veterinary use to be developed and approved, which can be expensive and time-consuming. Pet owners are starting to favor alternative therapies over conventional pain management goods and services, such as acupuncture and herbal medications. This may have a positive effect on market expansion. Veterinarian-assisted pain management has many benefits and is crucial to preserving animal's health and well-being.
As a platinum sponsor, Norbrook Laboratories Limited supported the International Society of Feline Medicine (ISFM) Congress in Dublin in June 2023. Veterinarians and nurses receive the information they need from the International Society of Feline Medicine (ISFM) to effectively address health issues in cats. Their annual congress was held in Dublin, and Norbrook Laboratories Limited was well-represented, emphasizing Thyronorm and Loxicom, their two primary cat products.
Rising Pet Ownership Leading to Market Expansion
The market for veterinary pain treatment is expanding due to the growing trend of pet ownership around the world. The need for veterinary services, particularly pain management, is rising in tandem with the number of households adopting pets. More people are turning to veterinarians for both acute and chronic pain disorders as a result of growing pet owners' awareness of the health and welfare of their animals. There has been an increase in regular veterinary visits as a result of this increased knowledge, and thus, pain management frequently becomes a point of focus. Effective pain management is necessary for conditions like arthritis, surgical pain, and age-related discomfort in pets. As a result, veterinary hospitals and clinics are broadening the scope of pain treatment services they provide, ranging from medication to physical therapy. Additionally, developments in veterinary medicine have enhanced diagnostic capacities, enabling earlier identification and more accurate management of pain. Since there is a deep emotional connection to their dogs, pet owners are prepared to spend money on cutting-edge pain relief techniques in order to prolong the lives of their pets. Innovations in pain management products, such as opioids, nonsteroidal anti-inflammatory medications (NSAIDs), nutraceuticals, and complementary therapies like laser and acupuncture, are also helping the industry. The availability of these varied alternatives gives vets the instruments required to customize pain management programs for specific animals, improving the results of treatment. The humanization of pets, in which animals are considered members of the family, also increases the need for superior veterinarian care. Given that pet owners are looking for thorough and sympathetic care for their animal companions, it is anticipated that this cultural shift will both sustain and accelerate the growth of the veterinary pain treatment industry.
For example, the acquisition of Ethos Veterinary Health by National Veterinary Associates (NVA) Compassion-First, which happened in 2023, illustrates how the expanding pet ownership trend is impacting the veterinary pain care sector. The increased need for specialized veterinary services, including pain management, is reflected through this acquisition. Expanding its offerings to incorporate Ethos's advanced pain management and specialist care, National Veterinary Associates Compassion-First, a network of more than 1,000 veterinary institutions, demonstrated the industry's response to the growing need for comprehensive pet healthcare brought on by the rise in pet ownership.
Huge Investments in Petcare Segment to Spur Market Growth
The veterinary pain management industry is growing at a high rate due to rising investments in pet care. Similar to developments in human healthcare, the demand for advanced healthcare services for pets is rising along with the number of pet owners. Pet owners are becoming more and more prepared to invest in their pets' health, which is driving up the number of veterinary appointments and operations that require efficient pain management techniques. Innovations in veterinary technology have resulted in the creation of novel and enhanced pain relief items, encompassing medications, nutritional plans, and medical apparatus. The increasing accessibility of these advancements prompts vets to implement more thorough pain management procedures, enhancing the standard of care and prolonging the lives of their patients. Furthermore, veterinary associations and animal welfare organizations' educational activities have raised public awareness about animal suffering and pain. This increased awareness prompts pet owners to look for prompt and efficient pain management solutions for their animals, which fuels the market's expansion even more. Insurance providers are also very important as these services are now more widely available to a larger audience because of growth of pet insurance policies that include coverage for pain management therapies. Pet owners have less financial strain because of this financial assistance, which motivates them to choose better pain management products. Long-term therapy solutions are in high demand since chronic illnesses, including cancer, arthritis, and post-surgical pain in dogs, are becoming more common and require constant pain management. Pharmaceutical companies are, therefore, making significant investments in R&D to produce safer and more effective animal analgesics. In conclusion, the market for veterinary pain management is expected to rise at a solid rate due to the convergence of rising chronic illness prevalence, increased awareness, expanding insurance coverage, and technological advancements.
For instance, leading animal health business, Zoetis Services LLC, introduced Solensia, a monoclonal antibody, in 2022 to help cats with osteoarthritis pain management. This cutting-edge product perfectly captures how the veterinary pain management business has been impacted by rising investments in pet healthcare. Through cutting-edge therapeutic solutions, Zoetis drove market growth by addressing a huge unmet need and offering a fresh, long-lasting pain management option.
Dominance of the NSAIDs Segment Drives Market Growth
In terms of revenue, nonsteroidal anti-inflammatory drugs (NSAIDs) hold the biggest market share and are predicted to grow at a notable CAGR during the forecast period. These medications are essential for the treatment of many different pain-related conditions in animals, including cancer and arthritis, as well as acute trauma and post-operative recovery. The best pain relief is provided by analgesics, which include both opioid and non-opioid painkillers. On the other hand, nonsteroidal anti-inflammatory drugs (NSAIDs) help to reduce inflammation and relieve pain brought on by several disorders. The need for these medications has grown as a result of the increasing frequency of these excruciating and inflammatory diseases in animals and pets, propelling market expansion. The increasing use of analgesic and anti-inflammatory drugs is indicative of a growing recognition among veterinarians and pet owners of the importance of pain management for the health and welfare of animals. More people are looking for holistic treatment for their pets, including effective pain management techniques, as the number of pet owners globally rises. Since untreated pain can significantly affect an animal's quality of life and general health, veterinarians are also taking an active approach to identifying and treating animal pain. Growing consumer knowledge is encouraging the use of a variety of painkillers, which is driving the market's expansion. Additionally, major players' endeavors, such as the introduction of new products, are accelerating the market's growth.
For example, Krka, tovarna zdravil, d.d., Novo mesto introduced Robexera, the first generic version of robenacoxib, in November 2023 to treat pain and inflammation in dogs resulting from soft tissue surgery and persistent osteoarthritis (OA).
North America Dominates the Veterinary Pain Management Market
North America holds the largest market share in the veterinary pain management market. This is because of the well-established veterinary healthcare infrastructure, the widespread use of cutting-edge technology, high disposable income, and the existence of significant businesses. These businesses' strategic actions keep boosting the expansion of the regional market. In April 2022, Zoetis Services LLC introduced AI blood smear testing for dogs and cats, enhancing its Vetscan Imagyst platform. Furthermore, the market under study is expanding due to the growing number of veterinary practitioners. For example, the U.S. Bureau of Labor Statistics stated in September 2022 that employment of veterinarians is expected to expand by 19% between 2021 and 2031, which is substantially greater than the average growth rate of all occupations. Additionally, according to the same source, there will be 4,800 expected openings for veterinarians annually on average during the next ten years. Hence, the growing number of veterinarians is fueling the demand for veterinary pain management services, which in turn is propelling the market under study's expansion. One of the main factors propelling market revenue growth in this region is the growing number of government efforts encouraging students to work in the veterinary health industry. For example, Ohio State's MPH-VPH veterinary healthcare program equips students with the public health credentials necessary to oversee zoonotic disease prevention and control initiatives across the nation.
Future Market Scenario (2024-2031F)
The main factors contributing to the anticipated growth of the veterinary pain management market are the rising pet ownership, increasing prevalence of zoonotic diseases, and thus, the rising requirement for pain management services. However, the growing need to have precision medicine to maintain healthy livestock animals and pets is also going to fuel the market growth in the future. Given that technology is advancing, cutting-edge technology in the field is expected to be developed. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion. For instance, PepiPets, Inc. launched a new mobile diagnostic testing service in August 2022. Its users were able to conduct diagnostic testing for their pets at home after the new service was introduced, according to a business announcement. Pets were supposed to feel more at ease with the treatment and spend less time traveling to an in-person office visit due to PepiPets Inc.'s at-home testing service.
Key Players Landscape and Outlook
Several companies such as Zoetis Services LLC, Boehringer Ingelheim Animal Health USA Inc., Vetoquinol, Dechra Veterinary Products Limited, Merck & Co., Inc., Ceva Sante Animale, Norbrook Laboratories Limited, Chanelle Pharma Group Ltd., Fear Free, LLC, Elanco, etc. are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed veterinary pain management services, to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.
For instance, with the establishment of its 35th VirbacGroup subsidiary, VirbacGroup finished acquiring all the shares of its previous distributor in Slovakia and the Czech Republic in May 2023. The teams under the direction of Jakub Satrapa, the company's previous owner and general manager of the upcoming subsidiary, worked hard for years to achieve this purchase. Their new VirbacGroup subsidiary would enable them to respond to the health needs of animals in Slovakia and the Czech Republic more quickly and efficiently.
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Veterinary Pain Management Market Outlook, 2017-2031F
4.1. Market Size Analysis & Forecast
4.1.1. By Value
4.1.2. By Volume
4.2. Market Share Analysis & Forecast
4.2.1. By Product
4.2.1.1. Drugs
4.2.1.1.1. By Type
4.2.1.1.1.1. NSAIDs
4.2.1.1.1.2. Opioids
4.2.1.1.1.3. Local Anesthetics
4.2.1.1.1.4. Alpha 2-Agonists
4.2.1.1.1.5. Others
4.2.1.1.2. By Route of Administration
4.2.1.1.2.1. Oral
4.2.1.1.2.2. Parenteral
4.2.1.1.2.3. Topical
4.2.1.2. Devices
4.2.1.2.1. Laser Therapy Devices
4.2.1.2.2. Electromagnetic Therapy Devices
4.2.2. By Application
4.2.2.1. Joint Pain
4.2.2.2. Post-Operative Pain
4.2.2.3. Cancer
4.2.2.4. Others
4.2.3. By Animal Type
4.2.3.1. Companion Animals
4.2.3.1.1. Dogs
4.2.3.1.2. Cats
4.2.3.1.3. Horses
4.2.3.1.4. Others
4.2.3.2. Livestock
4.2.3.2.1. Cattle
4.2.3.2.2. Swine
4.2.3.2.3. Others
4.2.4. By End-user
4.2.4.1. Veterinary Hospitals
4.2.4.2. Veterinary Clinics
4.2.4.3. Drug Stores and Pharmacies
4.2.5. By Region
4.2.5.1. North America
4.2.5.2. Europe
4.2.5.3. Asia-Pacific
4.2.5.4. South America
4.2.5.5. Middle East and Africa
4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
4.3.1. By Product
4.3.2. By Application
4.3.3. By Animal Type
4.3.4. By End-user
4.3.5. By Region
5. North America Veterinary Pain Management Market Outlook, 2017-2031F*
5.1. Market Size Analysis & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. Market Share Analysis & Forecast
5.2.1. By Product
5.2.1.1. Drugs
5.2.1.1.1. By Type
5.2.1.1.1.1. NSAIDs
5.2.1.1.1.2. Opioids
5.2.1.1.1.3. Local Anesthetics
5.2.1.1.1.4. Alpha 2-Agonists
5.2.1.1.1.5. Others
5.2.1.1.2. By Route of Administration
5.2.1.1.2.1. Oral
5.2.1.1.2.2. Parenteral
5.2.1.1.2.3. Topical
5.2.1.2. Devices
5.2.1.2.1. Laser Therapy Devices
5.2.1.2.2. Electromagnetic Therapy Devices
5.2.2. By Application
5.2.2.1. Joint Pain
5.2.2.2. Post-Operative Pain
5.2.2.3. Cancer
5.2.2.4. Others
5.2.3. By Animal Type
5.2.3.1. Companion Animals
5.2.3.1.1. Dogs
5.2.3.1.2. Cats
5.2.3.1.3. Horses
5.2.3.1.4. Others
5.2.3.2. Livestock
5.2.3.2.1. Cattle
5.2.3.2.2. Swine
5.2.3.2.3. Others
5.2.4. By End-user
5.2.4.1. Veterinary Hospitals
5.2.4.2. Veterinary Clinics
5.2.4.3. Drug Stores and Pharmacies
5.2.5. By Country Share
5.2.5.1. United States
5.2.5.2. Canada
5.2.5.3. Mexico
5.3. Country Market Assessment
5.3.1. United States Veterinary Pain Management Market Outlook, 2017-2031F*
5.3.1.1. Market Size Analysis & Forecast
5.3.1.1.1. By Value
5.3.1.1.2. By Volume
5.3.1.2. Market Share Analysis & Forecast
5.3.1.2.1. By Product
5.3.1.2.1.1. Drugs
5.3.1.2.1.1.1. By Type
5.3.1.2.1.1.1.1. NSAIDs
5.3.1.2.1.1.1.2. Opioids
5.3.1.2.1.1.1.3. Local Anesthetics
5.3.1.2.1.1.1.4. Alpha 2-Agonists
5.3.1.2.1.1.1.5. Others
5.3.1.2.1.1.2. By Route of Administration
5.3.1.2.1.1.2.1. Oral
5.3.1.2.1.1.2.2. Parenteral
5.3.1.2.1.1.2.3. Topical
5.3.1.2.1.2. Devices
5.3.1.2.1.2.1. Laser Therapy Devices
5.3.1.2.1.2.2. Electromagnetic Therapy Devices
5.3.1.2.2. By Application
5.3.1.2.2.1. Joint Pain
5.3.1.2.2.2. Post-Operative Pain
5.3.1.2.2.3. Cancer
5.3.1.2.2.4. Others
5.3.1.2.3. By Animal Type
5.3.1.2.3.1. Companion Animals
5.3.1.2.3.1.1. Dogs
5.3.1.2.3.1.2. Cats
5.3.1.2.3.1.3. Horses
5.3.1.2.3.1.4. Others
5.3.1.2.3.2. Livestock
5.3.1.2.3.2.1. Cattle
5.3.1.2.3.2.2. Swine
5.3.1.2.3.2.3. Others
5.3.1.2.4. By End-user
5.3.1.2.4.1. Veterinary Hospitals
5.3.1.2.4.2. Veterinary Clinics
5.3.1.2.4.3. Drug Stores and Pharmacies
5.3.2. Canada
5.3.3. Mexico
*All segments will be provided for all regions and countries covered
6. Europe Veterinary Pain Management Market Outlook, 2017-2031F
6.1.1. Germany
6.1.2. France
6.1.3. Italy
6.1.4. United Kingdom
6.1.5. Russia
6.1.6. Netherlands
6.1.7. Spain
6.1.8. Poland
7. Asia-Pacific Veterinary Pain Management Market Outlook, 2017-2031F
7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. Australia
7.1.5. Vietnam
7.1.6. South Korea
7.1.7. Indonesia
7.1.8. Philippines
8. South America Veterinary Pain Management Market Outlook, 2017-2031F
8.1.1. Brazil
8.1.2. Argentina
9. Middle East and Africa Veterinary Pain Management Market Outlook, 2017-2031F
9.1.1. Saudi Arabia
9.1.2. UAE
9.1.3. South Africa
9.1.4. Israel
10. Demand Supply Analysis
11. Import and Export Analysis
12. Value Chain Analysis
13. Porter's Five Forces Analysis
14. PESTLE Analysis
15. Pricing Analysis
16. Market Dynamics
16.1. Market Drivers
16.2. Market Challenges
17. Market Trends and Developments
18. Regulatory Framework and Innovation
18.1. Clinical Trials
18.2. Regulatory Approvals
19. Patent Landscape
20. Case Studies
21. Competitive Landscape
21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
21.3.1. Zoetis Services LLC
21.3.1.1. Company Details
21.3.1.2. Key Management Personnel
21.3.1.3. Products and Services
21.3.1.4. Financials (As Reported)
21.3.1.5. Key Market Focus and Geographical Presence
21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
21.3.2. Boehringer Ingelheim Animal Health USA Inc.
21.3.3. Vetoquinol
21.3.4. Dechra Veterinary Products Limited
21.3.5. Merck & Co., Inc.
21.3.6. Ceva Sante Animale
21.3.7. Norbrook Laboratories Limited
21.3.8. Chanelle Pharma Group Ltd.
21.3.9. Fear Free, LLC
21.3.10. Elanco
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
22. Strategic Recommendations
23. About Us and Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security